Immunovant, Inc.
IMVT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001764013
In the last 90 days, Immunovant, Inc. insiders filed 0 open-market purchases and 10 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.25B in total; Greenlight Capital is the only superinvestor holding it.
13F holders, Q1 2023
Institutional positions in Immunovant, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 142
- +9 vs. Q4 2022
- Shares held
- 58.3M
- +1.74M (+3.1%) vs. Q4 2022
- Total value
- $903.7M
- −$99.6M (−9.9%) vs. Q4 2022
- New holders
- 25
- 57 more added
- Sold out
- 16
- 42 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMVT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 226 | $4.25B |
| Q1 2026 | 216 | $2.75B |
| Q4 2025 | 197 | $2.76B |
| Q3 2025 | 186 | $1.53B |
| Q2 2025 | 169 | $1.54B |
| Q1 2025 | 194 | $1.62B |
| Q4 2024 | 187 | $1.98B |
| Q3 2024 | 182 | $2.26B |
| Q2 2024 | 197 | $1.97B |
| Q1 2024 | 209 | $2.27B |
| Q4 2023 | 228 | $2.88B |
| Q3 2023 | 181 | $2.57B |
| Q2 2023 | 147 | $1.05B |
| Q1 2023 | 142 | $903.7M |
| Q4 2022 | 133 | $1.00B |
| Q3 2022 | 112 | $238.1M |
| Q2 2022 | 94 | $156.5M |
| Q1 2022 | 112 | $218.6M |
| Q4 2021 | 118 | $322.4M |
| Q3 2021 | 119 | $293.6M |
| Q2 2021 | 110 | $407.5M |
| Q1 2021 | 120 | $654.3M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Immunovant, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Parkman Healthcare Partners LLC | 186,045 | $2.89M | 0.63% | +28,039+17.7% | Added |
| Morgan Stanley | 227,091 | $3.52M | 0.00% | +56,841+33.4% | Added |
| Hennion & Walsh Asset Management, Inc. | 227,556 | $3.53M | 0.22% | −26,080−10.3% | Reduced |
| Hillsdale Investment Management Inc. | 262,100 | $4.07M | 0.35% | +262,100 | New |
| Citigroup Inc | 285,367 | $4.43M | 0.01% | +182,796+178.2% | Added |
| Rafferty Asset Management, LLC | 327,916 | $5.09M | 0.03% | +97,343+42.2% | Added |
| Platinum Investment Management Ltd | 346,970 | $5.38M | 0.19% | −64,327−15.6% | Reduced |
| Voloridge Investment Management, LLC | 387,317 | $6.01M | 0.03% | +181,483+88.2% | Added |
| Charles Schwab Investment Management Inc | 388,467 | $6.03M | 0.00% | +1,813+0.5% | Added |
| Bank of America Corp | 409,814 | $6.36M | 0.00% | +175,011+74.5% | Added |
| Northern Trust Corp | 411,047 | $6.38M | 0.00% | −6,896−1.6% | Reduced |
| Goldman Sachs Group Inc | 440,858 | $6.84M | 0.00% | +69,610+18.8% | Added |
| Price T Rowe Associates Inc | 443,204 | $6.88M | 0.00% | +167,205+60.6% | Added |
| D. E. Shaw & Co., Inc. | 444,453 | $6.89M | 0.01% | +145,983+48.9% | Added |
| PFM Health Sciences, LP | 462,431 | $7.17M | 0.33% | +462,431 | New |
| Renaissance Technologies LLC | 492,112 | $7.63M | 0.01% | +148,012+43.0% | Added |
| Nuveen Asset Management, LLC | 522,396 | $8.10M | 0.00% | +198,478+61.3% | Added |
| Polar Asset Management Partners Inc. | 528,000 | $8.19M | 0.14% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 585,759 | $9.09M | 0.66% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 654,853 | $10.2M | 1.98% | −200,000−23.4% | Reduced |
| Victory Capital Management Inc | 665,785 | $10.3M | 0.01% | +665,785 | New |
| Ikarian Capital, LLC | 774,398 | $12.0M | 4.99% | −192,302−19.9% | Reduced |
| Two Sigma Advisers, LP | 840,100 | $13.0M | 0.03% | +459,200+120.6% | Added |
| Two Sigma Investments, LP | 972,870 | $15.1M | 0.04% | +615,833+172.5% | Added |
| Dimensional Fund Advisors LP | 1,031,963 | $16.0M | 0.01% | −265,645−20.5% | Reduced |
| Avidity Partners Management LP | 1,043,000 | $16.2M | 0.54% | +1,043,000 | New |
| Geode Capital Management, LLC | 1,048,718 | $16.3M | 0.00% | +45,123+4.5% | Added |
| Millennium Management LLC | 1,082,902 | $16.8M | 0.02% | +1,000,461+1,213.5% | Added |
| Citadel Advisors LLC | 1,165,876 | $18.1M | 0.02% | +193,154+19.9% | Added |
| Cowen and Company, LLC | 1,250,000 | $19.4M | 2.28% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 1,291,858 | $20.0M | 0.59% | +1,141,858+761.2% | Added |
| Redmile Group, LLC | 1,317,031 | $20.4M | 0.89% | +228,900+21.0% | Added |
| Eventide Asset Management, LLC | 1,390,000 | $21.6M | 0.40% | −2,303,720−62.4% | Reduced |
| Alpine Global Management, LLC | 1,439,544 | $22.3M | 8.67% | −60,456−4.0% | Reduced |
| Commodore Capital LP | 1,440,999 | $22.3M | 3.40% | +290,494+25.2% | Added |
| Logos Global Management LP | 2,500,000 | $38.8M | 5.55% | −650,000−20.6% | Reduced |
| BVF Inc | 2,561,000 | $39.7M | 1.45% | 00.0% | Unchanged |
| BlackRock Inc. | 3,937,181 | $61.1M | 0.00% | +7,757+0.2% | Added |
| State Street Corp | 3,967,605 | $61.5M | 0.00% | +854,662+27.5% | Added |
| FMR LLC | 4,146,969 | $64.3M | 0.01% | +1,658,836+66.7% | Added |
| Vanguard Group Inc | 5,143,709 | $79.8M | 0.00% | +74,590+1.5% | Added |
| Deep Track Capital, LP | 7,432,717 | $115.3M | 4.90% | −2,277,283−23.5% | Reduced |
| Walleye Capital LLC | 0 | $0 | 0.00% | −533,840−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −519,614−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −435,751−100.0% | Sold out |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −375,775−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −211,600−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −49,592−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −45,601−100.0% | Sold out |
| Jupiter Asset Management Ltd | 0 | $0 | 0.00% | −42,082−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −38,953−100.0% | Sold out |
| Kula Investments, LLC | 0 | $0 | 0.00% | −29,562−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −28,051−100.0% | Sold out |
| Concorde Asset Management, LLC | 0 | $0 | 0.00% | −16,725−100.0% | Sold out |
| Quantamental Technologies LLC | 0 | $0 | 0.00% | −12,301−100.0% | Sold out |
| Denali Advisors LLC | 0 | $0 | 0.00% | −3,900−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −224−100.0% | Sold out |